SCHEMBL1008613

SCHEMBL1008613

O=C(O)CCCCCCCC=Cc1cncs1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 2/20 0.51
ALDH1A1 P00352 7/20 0.43
F7 P08709 7/20 0.43
F3 P13726 7/20 0.43
PPARG P37231 5/20 0.43
PPARD Q03181 5/20 0.43
PPARA Q07869 5/20 0.43
CYP19A1 P11511 4/20 0.43
MAPT P10636 4/20 0.43
HSD17B10 Q99714 4/20 0.43
LMNA P02545 3/20 0.43
ALOX15 P16050 3/20 0.43
PTGS1 P23219 3/20 0.43
BLM P54132 3/20 0.43
FABP4 P15090 3/20 0.43
OXER1 Q8TDS5 2/20 0.43
KDM4E B2RXH2 2/20 0.43
FFAR1 O14842 2/20 0.43
CYP3A4 P08684 2/20 0.43
HPGD P15428 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1008612 1.00 TBXAS1 (0.51) TBXAS1ALDH1A1F7F3PPARG
SCHEMBL1007595 0.87 HDAC1 (0.39) TBXAS1ALDH1A1TSHRFAAH
SCHEMBL1007594 0.87 HDAC1 (0.39) TBXAS1ALDH1A1TSHRFAAH
SCHEMBL8079999 0.75 HPGD (0.53) TBXAS1ALDH1A1F7F3PPARG
SCHEMBL11472125 0.75 HPGD (0.53) TBXAS1ALDH1A1F7F3PPARG
SCHEMBL11472124 0.75 HPGD (0.53) TBXAS1ALDH1A1F7F3PPARG
SCHEMBL8079997 0.75 HPGD (0.53) TBXAS1ALDH1A1F7F3PPARG
SCHEMBL8091430 0.75 HPGD (0.53) TBXAS1ALDH1A1F7F3PPARG
SCHEMBL8091429 0.75 HPGD (0.53) TBXAS1ALDH1A1F7F3PPARG
SCHEMBL4412682 0.71 TBXAS1 (0.67) TBXAS1ALDH1A1F7F3PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268606-B1 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-08-06 EP disclosed
US-8344027-B2 4-dimethylaminobutyric acid derivatives HOFFMANN-LA ROCHE INC. (US) 2013-01-01 US disclosed
US-20120289554-A1 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES ANDJELKOVIC MIRJANA (CH) 2012-11-15 US disclosed
EP-2268606-A1 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES F. Hoffmann-La Roche AG (CH) 2011-01-05 EP disclosed
WO-2009132978-A1 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-11-05 WO disclosed
US-20090270505-A1 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES HOFFMANN-LA ROCHE, INC. 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270505-A1 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES CPT1B, CPT1A, CPT2 TBXAS1 1399/4885ALDH1A1 177/4885F7 4567/4885
US-20120289554-A1 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES CPT1B, CPT1A, CPT2 TBXAS1 1399/4885ALDH1A1 177/4885F7 4567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.